Successfully resolve to increase COVID, flu vaccination in the new year
By
Lois A. Bowers
Jan 02, 2024
If one of your new year’s resolutions is to increase influenza and COVID-19 vaccination among residents and staff members in 2024, results of a new research study published in JAMA Network Open provides...
Focus on briefs: Resident security
By
John Hall
Dec 03, 2023
Costs, along with changing attitudes, help fuel growth in deprescribing, Older Americans have access to more vaccines than ever, but increasing numbers cause concern for some individuals
Fourth COVID-19 shot beneficial in patients with autoimmune rheumatic diseases
Nov 28, 2023
A fourth dose reduces the risk for SARS-CoV-2 for patients with systemic autoimmune rheumatic diseases using DMARDs.
Coadministration of COVID-19, influenza vaccines seems effective
Nov 09, 2023
The researchers found that the incidence rates of emergency department or urgent care encounters and outpatient visits were slightly higher for the coadministration group versus the BNT162b2-biv-only group...
Bill would ban COVID-19 vaccine mandates despite older adults remaining at highest risk for serious outcomes
By
Kimberly Bonvissuto
Nov 02, 2023
A study underscoring the need to continue to protect older adults from COVID-19 comes as one state appears close to banning COVID-19 vaccine mandates by private employers, including senior living communities.
Medicare drug price negotiations: A game-changer for seniors’ healthcare
By
Luka Yancopoulos
Nov 02, 2023
The relatively recent passage of the Inflation Reduction Act, which among other provisions, allows Medicare to negotiate prescription drug prices, marks a monumental shift in senior healthcare in America.
Just 7 percent of US adults have gotten updated COVID-19 vaccine
Oct 27, 2023
The new shot targets a highly contagious variant that is in wide circulation nationwide.
Positive link identified between SARS-CoV-2 and Guillain-Barré
Oct 18, 2023
Odds ratio of 6.30 for Guillain-Barré syndrome association with SARS-CoV-2 infection and 0.41 for COVID-19 vaccine administration.